Skip to main content
. 2021 Sep 23;9(10):1299. doi: 10.3390/biomedicines9101299

Figure 5.

Figure 5

History of disease of the patient described as Case 2. Radiologic responses to TKI treatment paired with circulating activating and resistance EGFR mutation. PET-CT Images show size reduction without FDG-uptake, consisting with complete response, of the lung cancer localized in the left upper lobe (*) and adenopathy at subcarinal level (˄) from baseline (A) to controls at 3 and 6 months (B,C); PET-CT in the fourth image shows a relapse of tumor (D). Longitudinal VAF of delEx19 and T790M mutations in cfDNA (E).